Evaluation of thyroid hormones in type 1 diabetes mellitus
DOI:
https://doi.org/10.15218/zjms.2024.16Keywords:
Thyroid hormones (T3 andT4), TSH, Type 1 diabetes mellitusAbstract
Background and objective: Increased blood sugar levels (hyperglycemia) and lack of insulin are a hallmark of Type 1 diabetes mellitus (T1DM), which is a chronic autoimmune illness results from the destruction of pancreatic beta –cells. The most common causes of hypothyroidism and hyperthyroidism are autoimmune diseases Hashimoto's thyroiditis and Graves’ disease, respectively. Because type 1 diabetes includes autoimmunity as a pathophysiological trigger, it is not uncommon to investigate patients with both diabetes and thyroid problems. The aim of the study is to evaluate serum thyroid hormones in patients with type1 diabetes mellitus.
Methods: In this study 104 participants were included, 52 patients with type1 diabetes, and 52 healthy individuals. Blood samples were taken, and serum thyroid hormones levels were measured and the results of cases and controls were analyzed and compared using SPSS program.
Results: It was found that the levels of T4 among non- diabetic participants were higher than those of diabetic patients. (P <0.001). There is a negative correlation between BMI and fasting blood glucose in T1 diabetic patients according to regression test it has been shown that any increase in the FBG leads to decrease in the BMI.
Conclusion: The present study shows that type 1 diabetes mellitus may affect thyroid gland and thyroid hormone levels, that may result in thyroid dysfunction.
Metrics
References
Ghawil M, Tonutti E, Abusrewil S, Visentini D, Hadeed I, Miotti V, et al.Autoimmune thyroid disease in Libyan children and youngadults with type 1 diabetes mellitus. Eur J Pediatr 2011; 170: 983–7. DOI: https://doi.org/10.1007/s00431-010-1386-1.
Denzer C, Karges B, Nake A, Rosenbauer J, Schober E, Schwab KO, et al. Subclinical hypothyroidism and dyslipidemia in children andadolescents with type 1 diabetes mellitus. Eur J Endocrinol 2013; 168:601–8. DOI: https://doi.org/10.1530/EJE-12-0703.doi.org/10.1530EJE-12-0703
Warncke K, Frohlich-Reiterer EE, Thon A, Hofer SE, Wiemann D, €Holl RW. Polyendocrinopathy in children, adolescents, and youngadults with type 1 diabetes: a multicenter analysis of 28 671patients from the German/Austrian DPV-Wiss database. Diabetes Care 2010; 33:2010–2. DOI: https://doi.org/10.2337/dc10-0404.
Ziegler AG, Bonifacio E. Age-related islet atoantibody incidence in offspring of patients with type 1 diabetes. Diabetologia 2012; 55:1937–43. DOI: 10.1007/s00125-012-2472-x.
Jin P, Huang G, Lin J, Yang L, Xiang B, Zhou W,et al. High titre ofantiglutamic acid decarboxylase autoantibody is a strong predictorof the development of thyroid autoimmunity in patients with type 1diabetes and latent autoimmune diabetes in adults. Clin Endocrinol 2011; 74:587–92. DOI: 10.1111/j.1365-2265.2011.03976.x.
IDF and ISPAD. Global IDF/ISPAD Guideline for Diabetes in Childhood and Adolescence. 2011. Available at http://www.ispad.org/NewsFiles/IDF-ISPAD_Diabetes_in_Childhood_and%20Adolescence_Guidelines_2011.pdf Last accessed 09 September 2013.
Kadiyala R, Peter R, Okosieme OE. Thyroid dysfunction in patients with diabetes: clinical implications and screening strategies. Int J Clin Pract 2010; 64:1130–9. DOI: https://doi.org/10.1111/j.1742-1241.2010.02376.x.
Moriguchi M, Noso S, Kawabata Y, Yamamoto A, Ohno Y, Ikegami H, et al. Clinical and genetic characteristics of patients with autoimmune thyroid disease with anti-islet autoimmunity. Metabolism 2011; 60:761–6. DOI: https://doi.org/10.1016/j.metabol.2010.07.025
Jonsdottir B, Larsson C, Lundgren M, Ramelius A, Jonsson I, Larsson HE, et al. Childhood thyroid autoimmunity and relation to islet autoantibodies in children at risk for type 1 diabetes in the diabetes prediction in skane (DiPiS) study. Autoimmunity 2018; 51:228–37. DOI: https://doi.org/10.1080/08916934.2018.1519027
Cieluch A, Uruska A, Zozulinska-Ziolkiewicz D. Can We Prevent Mitochondrial Dysfunction and Diabetic Cardiomyopathy in Type 1 Diabetes Mellitus? Pathophysiology and Treatment Options. Int J Mol Sci 2020; 21:2852. DOI: https://doi.org/10.3390/ijms21082852.
Nevo-Shenker M, Phillip M, Nimri R. Type 1 diabetes mellitus management in young children: implementation of current technologies. Pediatr Res 2020; 87:624–9. DOI: https://doi.org/10.1038/s41390-019-0665-4.
Castellanos L, Tuffaha M, Koren D. Management of Diabetic Ketoacidosis in Children and Adolescents with Type 1 Diabetes Mellitus. Paediatr Drugs 2020. DOI: 10.1007/s40272-020-00397-0.
Benvenga S, Pintaudi B, Vita R, Vieste G D, Benedetto A D. Serum thyroid hormone autoantibodies in type 1 diabetes mellitus. J Clin Endocrinol Metab 2015; 100:1870–8. DOI:10.1210/jc.2014-3950
Ahi S, Amouzegar A, Gharibzadeh S, Delshad H, Tohidi M, Azizi F. Trend of lipid and thyroid function tests in adults without overt thyroid diseases: A cohort from Tehran thyroid study. PLoS One 2019; 14. DOI: https://doi.org/10.1371/journal.pone.0216389
Karar T, Alhammad RI, Fattah MA. Relation between glycosylated hemoglobin and lipid and thyroid hormone among patients with type 2 diabetes mellitus at King Abdulaziz Medical City, Riyadh. J Nat Sci Biol Med 2015; 6.
Finan B, Clemmensen C, Zhu Z, Tschop M H, Dimarchi R, Mulier T D, et al. Chemical Hybridization of Glucagon and Thyroid Hormone Optimizes Therapeutic Impact for Metabolic Disease. Cell 2016; 167:843–57. DOI: 10.1016/j.cell.2016.09.014
Amouzegar A, Kazemian E, Gharibzadeh S, Mehran L, Tohidi M, Azizi F. Association between thyroid hormones, thyroid antibodies and insulin resistance in euthyroid individuals: A population-based cohort. Diabetes Metab 2015; 41:480–8. DOI:10.1016/j.diabet.2015.04.004
Orzan A, Novac C, Mihu M, Tirgoviste CI, Balgradean M. Type 1 diabetes and thyroid autoimmunity in children. Maedica (Bucur) 2016; 11:308–12. PMID: 28828047.
Ali M, Kakar NH, Dawood R, Fatima Q, Tanveer Z, Malik SA, et al. Thyroid Abnormalities in Relation to Type 1 and Type 2 Diabetes Mellitus Patients in Quetta, Balochistan. Pakistan Zool 202; 53:1–6. DOI:10.17582/journal.pjz/20191012171020.
Peters KE, Chubb SAP, Bruce DG, Davis WA, Davis TME. Prevalence and incidence of thyroid dysfunction in type 1 diabetes, type 2 diabetes and latent autoimmune diabetes of adults: The Fremantle Diabetes Study Phase II, Clinical Endocrinology 2021; 92:373–82. DOI: https://doi.org/10.1111/cen.14164.
Ayub F, Naheed M, Anwar A. Frequency of Abnormal Thyroid Function Tests in Type 1 and Type 2 Diabetic Patients. European Academic Research 2021; 9(8):5364–80.
Iweka FK, Okogun GRA, Dic-Ijiewere EO, Dada LF, Akhuemokhan IK, Obodo BN, et al. Assessment of thyroid profile of type 1 and type 2 diabetes mellitus patients and patients with diabetic complications. Recent Adv Biol Med 2020; 6(2):1110909. DOI: 10.18639/rabm.2020.1110909.
Elmenshawi IM, Alotaibi S, Alazmi AS, Alazmi AM, Alruwaili FR. Prevalence of Thyroid Dysfunction in Diabetic Patients. J Diabetes Metab Disord Control 2017; 4(2):00106. DOI: 10.15406/JDMDC.2017.04.00106
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Amna Abdullah, Sardar N. Ahmed (Author)
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
The copyright on any article published in Zanco J Med Sci is retained by the author(s) in agreement with the Creative Commons Attribution Non-Commercial ShareAlike License (CC BY-NC-SA 4.0).
